Adults 18 to 70, any sex, with Generalized Anxiety or Health Anxiety. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
GAD-7Primary· 8 weeks
Generalized Anxiety Disorder 7-item scale (range 0-21, higher score indicates more pronounced anxiety). A change score is calculated based on baseline score minus week 8 score.
Group
Value
95% CI
Anxiety Reduction Training (A.R.T.)
4.7
± 4.4
ART and Kundalini Yoga
7.8
± 2.9
ART and Meditation
4.9
± 4.6
Whiteley 8Primary· 8 weeks
Health Anxiety 8-item scale (range 0-32, higher score indicates more pronounced anxiety). A change score is calculated based on baseline score minus week 8 score.
Group
Value
95% CI
Anxiety Reduction Training (A.R.T.)
0.05
± 4.9
ART and Kundalini Yoga
3.9
± 3.4
ART and Meditation
2.5
± 4.5
PHQ-8Secondary· 8 weeks
Patient Health Questionnaire 8 - an 8 item measure of depression (range 0-24, higher score indicates more pronounced depression). A change score is calculated based on baseline score minus week 8 score.
Group
Value
95% CI
Anxiety Reduction Training (A.R.T.)
4.8
± 3.7
ART and Kundalini Yoga
7.8
± 5.3
ART and Meditation
4.5
± 6.1
SS-8Secondary· 8 weeks
Somatic Symptom Scale-8 an 8-item measure of symptom burden (range 0-32, higher score represents worsening of somatic symptoms). A change score is calculated based on baseline score minus week 8 score.
Group
Value
95% CI
Anxiety Reduction Training (A.R.T.)
-3.8
± 4.4
ART and Kundalini Yoga
-2.8
± 4.1
ART and Meditation
-1.7
± 4.5
Applied Cognition 1.0Secondary· 8 weeks
An 8-item self-report measure of cognitive function (range 8-40, higher is better). A change score is calculated based on baseline score minus week 8 score.
Group
Value
95% CI
Anxiety Reduction Training (A.R.T.)
-4.1
± 5.5
ART and Kundalini Yoga
-6.6
± 5.5
ART and Meditation
-5.1
± 6.5
PROMIS-4 Sleep DisturbanceSecondary· 8 weeks
A 4-item self-report assessment of sleep disturbance (range 4-20, higher score indicates more sleep disturbance). A change score is calculated based on baseline score minus week 8 score.
Group
Value
95% CI
Anxiety Reduction Training (A.R.T.)
1.5
± 3.0
ART and Kundalini Yoga
3.7
± 3.8
ART and Meditation
3.3
± 4.3
ERQSecondary· 8 weeks
Emotional Regulation Questionnaire - a 10-item measure of emotional regulation; the reappraisal subscale has a range: of 6-42, higher score reflects improvement; while the suppression subscale has a range of 4-28, higher score considered worsening status. A change score is calculated based on baseline score minus week 8 score.
Reappraisal Subscale
Group
Value
95% CI
Anxiety Reduction Training (A.R.T.)
-1.9
± 4.7
ART and Kundalini Yoga
-5.5
± 7.8
ART and Meditation
-2.9
± 6.3
Suppression Subscale
Group
Value
95% CI
Anxiety Reduction Training (A.R.T.)
-16.2
± 8.1
ART and Kundalini Yoga
-13.9
± 9.1
ART and Meditation
-16.5
± 8.9
Perceived Stress ScaleSecondary· 8 weeks
A 10-item scale assessing the perception of events in one's life as stressful (0-40, higher score indicates more pronounced perception of stress).A change score is calculated based on baseline score minus week 8 score.
Group
Value
95% CI
Anxiety Reduction Training (A.R.T.)
4.1
± 6.5
ART and Kundalini Yoga
6.0
± 5.9
ART and Meditation
6.5
± 8.1
Brief Hypervigilance ScaleSecondary· 8 weeks
A 5-item scale assessing hypervigilance (0-20, higher score indicates greater hypervigilance). A change score is calculated based on baseline score minus week 8 score.
Group
Value
95% CI
Anxiety Reduction Training (A.R.T.)
1.2
± 2.4
ART and Kundalini Yoga
3.5
± 4.1
ART and Meditation
0.4
± 3.2
Sponsor's own description
This randomized clinical on-line study examines whether whether a daily practice of meditation or Kundalini Yoga with anxiety reduction training leads to a greater reduction in anxiety than anxiety reduction training alone.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Research Foundation for Mental Hygiene, Inc.
Last refreshed: 19 September 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04386291.